血管认知障碍风险因素的复杂相互作用和复合负担
1Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Journal of the neurological sciences
|December 29, 2024
概括
管理血管风险因素 (VRF) 是血管认知障碍 (VCI) 的关键. 本综述探讨了VRF之间的复杂相互作用及其对VCI的影响,强调了超越单一因素管理的综合战略的需要.
科学领域:
- 神经学 神经学
- 血管医学 血管医学
- 老年学是一门学科.
背景情况:
- 血管认知障碍 (VCI) 涵盖了一系列与血管因素相关的认知衰退.
- 目前的管理重点是症状治疗和解决个体血管风险因素 (VRF).
- 管理单个VRF是不够的,因为VCI的复杂性和风险因素的综合影响.
研究的目的:
- 审查VCI中VRF之间的复杂相互作用的临床证据.
- 探索这些相互作用对VCI进展和预防的影响.
- 总结当前的风险评估工具,并建议未来的研究方向.
主要方法:
- 对VCI和VRF相互作用的临床证据的文献综述.
- 对研究VRF组合及其对认知衰退的影响进行分析.
- 关于VCI的现有和新型风险预测模型的摘要.
主要成果:
- VCI管理需要解决多个VRF之间的复杂相互作用,而不仅仅是单个因素.
- 了解并发性VRF影响对于识别风险人群至关重要.
- 用于VCI风险评估的各种风险评分和模型,包括人工智能驱动的风险评分和模型.
结论:
- 针对联合VRF的综合战略对于VCI的预防和管理至关重要.
- 需要进一步的研究来完善风险分析,制定有效的风险评分,并实施有针对性的干预措施.
- 识别特定的临床风险概况可以改善VCI风险预测和预防工作.
相关概念视频
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
Dementia
94
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
94
Cognitive Development During Adulthood
50
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
50
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Psychoneuroimmunology: Cardiovascular Disease
25
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
25
Alzheimer's Disease: Treatment
162
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
162


